Alan H. Auerbach

Insider Reports History

Reporting-owner location: Los Angeles, CA
Latest reporting-owner signature: /s/ Gordon Esplin as attorney-in-fact for Alan H. Auerbach
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Alan H. Auerbach

Form 4 holding President and CEO, Director, 10%+ Owner

PUMA BIOTECHNOLOGY, INC.

Security class: Common Stock
Shares / value: 7,261,671
Estimated value: $60,003,187
Report date: 06 Jul 2026
Price: $8.26
Ownership: Direct

Form 4 holding President and CEO, Director, 10%+ Owner

PUMA BIOTECHNOLOGY, INC.

Security class: Stock Option (Right to Buy)
Shares / value: 227,474
Estimated value
Report date: 18 Feb 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Alan H. Auerbach

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 06 Jul 2026
Transactions: 1
Transaction value: -$364,051
Accepted by SEC: 08 Jul 2026, 20:21
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 18 Feb 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 20 Feb 2026, 20:29
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 06 Jan 2026
Transactions: 2
Transaction value: -$204,878
Accepted by SEC: 08 Jan 2026, 20:27
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 08 Jul 2025
Transactions: 2
Transaction value: -$166,702
Accepted by SEC: 10 Jul 2025, 20:49
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 07 Feb 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 11 Feb 2025, 18:51
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Jan 2025
Transactions: 1
Transaction value: -$106,657
Accepted by SEC: 03 Jan 2025, 19:12
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 17 Jul 2024
Transactions: 1
Transaction value: -$81,128
Accepted by SEC: 18 Jul 2024, 18:50
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Jul 2024
Transactions: 1
Transaction value: -$61,726
Accepted by SEC: 02 Jul 2024, 21:10
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 15 Mar 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 19 Mar 2024, 21:01
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 12 Feb 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 14 Feb 2024, 17:58
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 03 Jan 2024
Transactions: 1
Transaction value: -$185,698
Accepted by SEC: 05 Jan 2024, 18:56
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 03 Jul 2023
Transactions: 1
Transaction value: -$200,983
Accepted by SEC: 06 Jul 2023, 19:03
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 10 Feb 2023
Transactions: 2
Transaction value: $0
Accepted by SEC: 14 Feb 2023, 15:39
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 03 Jan 2023
Transactions: 1
Transaction value: -$113,810
Accepted by SEC: 05 Jan 2023, 16:29
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 12 Dec 2022
Transactions: 1
Transaction value: +$2,499,996
Accepted by SEC: 12 Dec 2022, 18:58
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Dec 2022
Transactions: 1
Transaction value: -$5,627
Accepted by SEC: 06 Dec 2022, 15:37
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Nov 2022
Transactions: 1
Transaction value: -$2,794
Accepted by SEC: 04 Nov 2022, 16:17
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 03 Oct 2022
Transactions: 1
Transaction value: -$2,943
Accepted by SEC: 05 Oct 2022, 16:32
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Sep 2022
Transactions: 1
Transaction value: -$3,247
Accepted by SEC: 07 Sep 2022, 16:36
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Aug 2022
Transactions: 1
Transaction value: -$3,604
Accepted by SEC: 04 Aug 2022, 18:42
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 05 Jul 2022
Transactions: 1
Transaction value: -$68,787
Accepted by SEC: 07 Jul 2022, 20:21
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Jun 2022
Transactions: 1
Transaction value: -$2,333
Accepted by SEC: 06 Jun 2022, 17:01
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 03 May 2022
Transactions: 1
Transaction value: -$2,930
Accepted by SEC: 04 May 2022, 18:37
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 04 Apr 2022
Transactions: 1
Transaction value: -$3,687
Accepted by SEC: 05 Apr 2022, 17:41
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 03 Mar 2022
Transactions: 3
Transaction value: +$4,999,998
Accepted by SEC: 14 Mar 2022, 19:58
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Mar 2022
Transactions: 1
Transaction value: -$2,919
Accepted by SEC: 04 Mar 2022, 16:07
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Feb 2022
Transactions: 1
Transaction value: -$3,239
Accepted by SEC: 03 Feb 2022, 16:29
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 03 Jan 2022
Transactions: 1
Transaction value: -$72,923
Accepted by SEC: 05 Jan 2022, 16:12
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Dec 2021
Transactions: 1
Transaction value: -$5,327
Accepted by SEC: 06 Dec 2021, 17:31
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Nov 2021
Transactions: 1
Transaction value: -$10,112
Accepted by SEC: 03 Nov 2021, 18:17
Role: PRESIDENT AND CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 04 Oct 2021
Transactions: 1
Transaction value: -$11,433
Accepted by SEC: 06 Oct 2021, 17:04
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Sep 2021
Transactions: 1
Transaction value: -$13,403
Accepted by SEC: 03 Sep 2021, 21:27
Role: PRESIDENT AND CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Aug 2021
Transactions: 1
Transaction value: -$13,286
Accepted by SEC: 03 Aug 2021, 17:45
Role: PRESIDENT AND CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Jul 2021
Transactions: 1
Transaction value: -$47,121
Accepted by SEC: 06 Jul 2021, 19:42
Role: PRESIDENT AND CEO, Director, 10%+ Owner
Next action: Open filing details

4 PBYI

PUMA BIOTECHNOLOGY, INC.

Report period: 02 Jun 2021
Transactions: 1
Transaction value: -$18,877
Accepted by SEC: 04 Jun 2021, 16:49
Role: PRESIDENT AND CEO, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .